Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers ...
The Diagnostics Advisory Committee reviewed the evidence available on the clinical and cost effectiveness of self‑monitoring coagulometers for self‑testing or self‑managing coagulation status in ...
The assessment consisted of a systematic review of the evidence on test performance and clinical‑effectiveness data for the CoaguChek XS system, the INRatio2 PT/INR monitor, the ProTime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results